(3S,4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-iumbromide-D3; (5?)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-(methyl-d3)-6-oxomorphinanium Bromide; Methylnaltrexone-d3; Methylnaltrexone-d3 Bromide; N-Cyclopropylmethyl-noroxymorphone Methobromide-d3; N-Methylnaltrexone-d3 Bromide; Naltrexone Methyl-d3 Bromide; Naltrexone Methobromide-d3; Relistor-d3; MRZ 2663BR-d3
Methylnaltrexone-d3 Bromide is a fully characterized chemical compound used as a reference standard of API Naltrexone. The standard offered is compliant with regulatory guidelines. Methylnaltrexone-d3 Bromide is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 73232-52-7 (non-d)
